Relafen 750, chemically known as naproxen , offers a distinct biochemical approach to treating pain associated with osteoarthritis . From a biochemical standpoint , its action involves preferential inhibition of prostaglandin synthesis, a vital enzyme involved in the production of inflammatory mediators . This pathway differs from traditional NSAID